MarketCap
Atara Biotherapeutics ATRA
€ 7.47
1.1%
Facebook
X
Telegram
Atara Biotherapeutics Kurshistorie | ATRA
Kurshistorie Jährlich Atara Biotherapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.87 | 6.81 | 0.69 | 5.09 | 15.8 | 19.6 | 16.5 | 34.7 | 18.1 | 14.2 | 26.4 | 26.8 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 34.7 | 0.69 | 15.9 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Repare Therapeutics
RPTX
|
1.18 | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
0.63 | - | 7.29 % | $ 127 M |  USA |
 |
Windtree Therapeutics
WINT
|
1.3 | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
6.06 | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
0.59 | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
3.07 | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
0.09 | - | - | $ 13 M | USA |
 |
Lyra Therapeutics
LYRA
|
6.24 | - | - | $ 24.9 M | USA |
 |
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
1.66 | - | - | $ 8.86 M | Canada |
 |
Generation Bio Co.
GBIO
|
2.77 | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
1.64 | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
46.4 | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
1.16 | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
4.96 | $ 4.2 | -0.36 % | $ 651 M | USA |
 |
AbbVie
ABBV
|
226 | $ 294.72 | 0.32 % | $ 521 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
0.74 | $ 4.63 | 21.05 % | $ 20 M |  Israel |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
Achieve Life Sciences
ACHV
|
2.9 | $ 6.78 | 0.89 % | $ 296 M | USA |
 |
Axon Enterprise
AXON
|
392 | $ 316.97 | 4.77 % | $ 24.7 B | USA |
|
TFF Pharmaceuticals
TFFP
|
6.05 | - | -60.05 % | $ 125 K | USA |
 |
Bristol-Myers Squibb Company
BMY
|
60.2 | $ 62.89 | 0.18 % | $ 128 B | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Axcella Health
AXLA
|
0.46 | - | -16.42 % | $ 249 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
62.8 | $ 58.59 | 4.29 % | $ 7.04 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
13.3 | - | - | $ 2.02 B | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
311 | $ 159.75 | 5.35 % | $ 20.9 B | USA |
 |
Amgen
AMGN
|
369 | $ 467.97 | 0.59 % | $ 252 B | USA |
 |
Orgenesis
ORGS
|
0.5 | - | -33.86 % | $ 61.2 M | USA |
 |
Codiak BioSciences
CDAK
|
11.1 | - | -55.98 % | $ 2.15 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
173 | $ 248.31 | 1.17 % | $ 15.1 B |  Irlanda |
 |
Johnson & Johnson
JNJ
|
157 | $ 280.31 | -0.17 % | $ 675 B | USA |
 |
Kala Pharmaceuticals
KALA
|
0.2 | $ 0.17 | 0.64 % | $ 1.39 M | USA |
 |
BioLineRx Ltd.
BLRX
|
2.29 | $ 1.49 | -1.97 % | $ 3.67 B | Israel |
 |
Sage Therapeutics
SAGE
|
7.15 | - | - | $ 527 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 1.59 | -2.76 % | $ 2.62 M | Israel |
 |
Lineage Cell Therapeutics
LCTX
|
1.83 | $ 1.13 | 8.17 % | $ 260 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
1.49 | - | - | $ 121 M | USA |
 |
TCR2 Therapeutics
TCRR
|
1.5 | - | - | $ 58.1 M | USA |
 |
C4 Therapeutics
CCCC
|
2.82 | $ 2.9 | -3.5 % | $ 240 M | USA |
 |
Eli Lilly and Company
LLY
|
1.05 K | $ 1 437.4 | 0.36 % | $ 1.29 T | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
0.955 | - | -14.27 % | $ 1.7 M |  Singapore |
 |
Compugen Ltd.
CGEN
|
2.1 | $ 2.09 | -0.24 % | $ 195 M | Israel |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
43.7 | $ 84.95 | 0.13 % | $ 7.99 B | USA |